VolitionRX Ltd (VNRX) Stock at a key inflection point
The Benchmark Company raised the price target for the VolitionRX Ltd (AMEX:VNRX) stock from “a Buy” to “a Hold”. The rating was released on February 01, 2023, according to finviz. We previously noted in another research note published on February 17, 2022 by Cantor Fitzgerald that resumed the stock to an Overweight with a price […]
